The present study demonstrated that co-exposure to AD particles and antigen during the sensitization phase of a mouse model of asthma augmented neutrophilic and eosinophilic airway inflammation, as demonstrated by increased levels of CysLTs and LTB4, which could be attenuated by the CysLT1 receptor antagonist (Prl). This evidence concerns the gene PRL and Alzheimer disease.